Molina Healthcare, Inc.
NYSE•MOH
CEO: Mr. Joseph Michael Zubretsky
Sector: Healthcare
Industry: Medical - Healthcare Plans
Listing Date: 2003-07-02
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Contact Information
Market Cap
$7.28B
P/E (TTM)
15.2
24.3
Dividend Yield
--
52W High
$359.97
52W Low
$121.06
52W Range
Rank28Top 16.1%
5.3
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$11.38B+0.00%
4-Quarter Trend
EPS
-$3.15+0.00%
4-Quarter Trend
FCF
-$297.00M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Premium Revenue Increased 11% Premium revenue reached $43.1B USD, up 11% driven by ConnectiCare acquisition and Medicaid rate increases.
Net Income Dropped Significantly Net income fell to $472M USD from $1.179B USD due to higher medical costs outpacing revenue rates.
Medical Care Ratio Spiked Consolidated MCR rose 260 basis points to 91.7% reflecting challenging medical cost trends across all operating segments.
Medicaid Membership Declined Total membership slightly decreased to 5.491M members; Medicaid lost 322K members due to eligibility redeterminations.
Risk Factors
Medicaid Rates Lag Costs Fixed Medicaid rates may not keep pace with rising utilization and medical cost trends, compressing margins significantly.
Marketplace Subsidy Expiration Expiration of enhanced premium tax credits (APTCs) after 2025 could reduce Marketplace participation and membership levels.
OBBBA Medicaid Enrollment Risk New OBBBA legislation expected to cause 15% to 20% reduction in Medicaid Expansion enrollment by 2029.
Incurred Claims Estimation Risk Estimating IBNP liability requires significant judgment; cost trend variations could materially impact financial results.
Outlook
Pursuing Government Contracts Strategy focuses on pure-play government business, targeting 11% to 13% long-term premium revenue growth.
Exiting MAPD Product Line Intends to exit MAPD product in 2027 to focus exclusively on higher acuity dual-eligible Medicare members.
Share Repurchase Authorization Board authorized up to $1B share repurchase program through December 31, 2026, demonstrating capital deployment focus.
New Contract Revenue Secured 2025 RFP wins secured nearly $9B in incremental annual Medicaid premium revenue expected to commence in 2026.
Peer Comparison
Revenue (TTM)
$45.43B
$13.64B
$13.18B
Gross Margin (Latest Quarter)
95.6%
77.4%
72.0%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| MRNA | $21.71B | -7.6 | -30.1% | 15.5% |
| PEN | $13.21B | 74.3 | 13.4% | 12.0% |
| ENSG | $12.18B | 35.1 | 16.6% | 76.1% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
0.7%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
25%
Cash Flow Needs Attention
Deep Research
Next earnings:Apr 21, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data